Nevertheless, bortezomib significantly downregulated BMI1 in MM cells as reported in mantle cell lymphoma cells23, and PTC596 enhanced the bortezomib-induced reductions in BMI1 protein levels in MM cells. The gene discussed is BMI1; the disease is Miyoshi myopathy.